[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0490920T3 - Mavesyrebindende farmaceutisk præparat - Google Patents

Mavesyrebindende farmaceutisk præparat

Info

Publication number
DK0490920T3
DK0490920T3 DK90912814.2T DK90912814T DK0490920T3 DK 0490920 T3 DK0490920 T3 DK 0490920T3 DK 90912814 T DK90912814 T DK 90912814T DK 0490920 T3 DK0490920 T3 DK 0490920T3
Authority
DK
Denmark
Prior art keywords
acid
pct
active substance
effervescent system
date mar
Prior art date
Application number
DK90912814.2T
Other languages
English (en)
Inventor
Thomas Gergely
Irmgard Gergely
Gerhard Gergely
Original Assignee
Gerhard Gergely
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerhard Gergely filed Critical Gerhard Gergely
Application granted granted Critical
Publication of DK0490920T3 publication Critical patent/DK0490920T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90912814.2T 1989-09-07 1990-09-06 Mavesyrebindende farmaceutisk præparat DK0490920T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH326089 1989-09-07
CH336689 1989-09-15
CH53290 1990-02-20

Publications (1)

Publication Number Publication Date
DK0490920T3 true DK0490920T3 (da) 1994-04-25

Family

ID=27172187

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90912814.2T DK0490920T3 (da) 1989-09-07 1990-09-06 Mavesyrebindende farmaceutisk præparat

Country Status (9)

Country Link
US (1) US5260304A (da)
EP (1) EP0490920B1 (da)
JP (1) JP2907299B2 (da)
AT (1) ATE98122T1 (da)
DE (1) DE59003811D1 (da)
DK (1) DK0490920T3 (da)
ES (1) ES2052471T3 (da)
FI (1) FI100855B (da)
WO (1) WO1991003241A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2106861C1 (ru) * 1991-01-30 1998-03-20 Дзе Веллкам Фаундейшн Лимитед Диспергируемые в воде таблетки, способ их получения, гранулы и диспергирующий агент для получения таблеток
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
US5447918A (en) * 1992-07-27 1995-09-05 Mccullough; Ricky W. Gastrointestinal anti-irritant composition comprising sucralfate and methods of use
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
FR2703250A1 (fr) * 1993-03-30 1994-10-07 Chicouri Marcel Nouvelles compositions pharmaceutiques à base de bismuth et leur procédé de préparation.
US5993860A (en) * 1993-06-17 1999-11-30 Venture Lending NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) * 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
CN1177357A (zh) * 1995-01-26 1998-03-25 耐克麦德英梅金公司 铋化合物
WO1996023507A1 (fr) * 1995-02-02 1996-08-08 Chugai Seiyaku Kabushiki Kaisha Preparation de sucralfate
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
WO1996031218A1 (fr) * 1995-04-03 1996-10-10 Chugai Seiyaku Kabushiki Kaisha Composition pharmaceutique contenant du sucralfate
KR20000019144A (ko) * 1998-09-09 2000-04-06 이수근 태양전지를이용한휴대용다중전원장치
US6683043B1 (en) * 1998-12-08 2004-01-27 The Procter & Gamble Company Process for manufacturing effervescence components
US20040142903A1 (en) * 2003-01-16 2004-07-22 Par Pharmaceutical Inc. Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP3263117A1 (en) 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
DE102006054260A1 (de) * 2006-02-28 2007-09-27 Lohmann Animal Health Gmbh & Co. Kg Wasser stabilisierende Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
KR20170003414A (ko) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 속붕해형 과립환 모발 세정용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB514888A (en) * 1937-03-20 1939-11-21 Alfred Washington Pauley Effervescent composition containing magnesium hydroxide and method of making same
GB524756A (en) * 1938-03-17 1940-08-14 Chas H Phillips Chemical Co Medicinal preparations of magnesium hydroxide and precess of obtaining the same
AU1087883A (en) * 1982-02-02 1983-08-11 Bayer Aktiengesellschaft Water dispersible, soluble granules
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
DE3627475A1 (de) * 1986-06-26 1988-01-14 Gergely Gerhard Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung
US4801454A (en) * 1986-07-17 1989-01-31 The Proctor & Gamble Company Processes for making colored pharmaceutical compositions
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat

Also Published As

Publication number Publication date
JP2907299B2 (ja) 1999-06-21
ATE98122T1 (de) 1993-12-15
ES2052471T1 (es) 1994-07-16
US5260304A (en) 1993-11-09
EP0490920A1 (de) 1992-06-24
JPH05500052A (ja) 1993-01-14
FI910802A0 (fi) 1991-02-19
WO1991003241A1 (de) 1991-03-21
EP0490920B1 (de) 1993-12-08
DE59003811D1 (de) 1994-01-20
FI100855B (fi) 1998-03-13
ES2052471T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
DK0490920T3 (da) Mavesyrebindende farmaceutisk præparat
US4863898A (en) Amino acid chelated compositions for delivery to specific biological tissue sites
Kabata-Pendias et al. Trace elements in abiotic and biotic environments
CA1275926C (en) Veterinary composition containing actively absorbed monosaccharide
GR3003685T3 (da)
ZA894828B (en) Process for the preparation of anti-inflammatory pharmaceutical agents with an ibuprofen base,with elimination,in solution,of the bitter taste,burning of the throat and intestinal toxicity
WO1996010409A3 (en) Liquid antacid compositions containing calcium carbonate and possibly simethicone as active compounds and monobasic potassium phosphate and potassium bicarbonate as buffer
US5723453A (en) Stabilized, water-soluble aspirin composition
EP0205174A2 (en) Dietary food of seaweed having ion-exchange capability
CA2045709A1 (en) Herbicidal composition
JPS57100177A (en) Mixed agent composition of amino acid with saccharide
ES2023391B3 (es) Polvos adecuados para bebidas.
TH10515EX (th) สารผสมฆ่าวัชพืช
JPS57118510A (en) Method of increasing absorption of membrane-absorptive preparation on administration
JPS6348210A (ja) 易溶性顆粒
GB1581826A (en) Veterinary compositions for treating diarrhoea
Basilico et al. Detoxification of corn contaminated with deoxynivalenol(vomitoxin) using sodium bisulfite. Effect on Wistar rats[Detoxificacion de maiz contaminado con deoxinivalenol(vomitoxina) utilizando bisulfito de sodio. Efecto en ratas Wistar]
TH21547A (th) สูตรผสมทางเภสัชกรรมที่เป็นของเหลวของแอลจิเนท และโพแทสเซียมไบคาร์บอเนต
TH8916B (th) สูตรผสมทางเภสัชกรรมที่เป็นของเหลวของแอลจิเนท และโพแทสเซียมไบคาร์บอเนต
RU93032434A (ru) Способ профилактики желудочно-кишечных болезней новорожденных телят

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment